Thu, November 10, 2022

Mani Foroohar Maintained (ARWR) at Hold with Increased Target to $33 on, Nov 10th, 2022

Mani Foroohar of SVB Leerink, Maintained "Arrowhead Pharmaceuticals, Inc." (ARWR) at Hold with Increased Target from $32 to $33 on, Nov 10th, 2022.

Mani has made no other calls on ARWR in the last 4 months.



There are 2 other peers that have a rating on ARWR. Out of the 2 peers that are also analyzing ARWR, 1 agrees with Mani's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Andrew Galler of "Morgan Stanley" Initiated at Hold and Held Target at $41 on, Friday, September 9th, 2022


This is the rating of the analyst that currently disagrees with Mani


  • Madhu Kumar of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $65 on, Monday, August 8th, 2022